LENSAR, Inc. (LNSR)
Data as of , from SEC Form 4 filings.
See up to 3 months of LNSR. The 7-day demo opens the 1M and 3M ranges and puts LNSR on your watchlist.
Start 7-day demoLatest LNSR insider trades
About LENSAR, Inc. (LNSR)
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
- ORLANDO, FL
- 150
- 2020
- XNAS
LNSR Form 4 activity by transaction type, last 90 days
No Form 4 activity for LNSR in the last 90 days.
LNSR insider transactions (Form 4)
2726 Form 4 filings on record, the earliest from May 23, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Todd B. Hammer | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Thomas B. Ellis | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Kendra Wong - Officer | Grant or award | Common Stock | 13,066 footnote F1 | $0.00 | - | |
| ||||||
 Alan B. Connaughton - Officer | Grant or award | Common Stock | 34,843 footnote F1 | $0.00 | - | |
| ||||||
 Nicholas T. Curtis - Officer | Grant or award | Common Stock | 130,662 footnote F1 | $0.00 | - | |
| ||||||
| Aimee S. Weisner | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Elizabeth G. O'Farrell | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Gary M. Winer | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Richard L. Md Lindstrom | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| William J. Phd Link | Grant or award | Common Stock | 17,421 footnote F1 | $0.00 | - | |
| ||||||
| Nicholas T. Curtis - Officer | Other | Common Stock | 0 footnote F1 | $0.00 | - | |
| ||||||
| Alan B. Connaughton - Officer | Tax withholding / forfeiture | Common Stock | 2,739 footnote F1 | $5.39 | $15K | |
| ||||||
 Thomas R. Staab II - Officer | Tax withholding / forfeiture | Common Stock | 1,350 footnote F1 | $5.39 | $7K | |
| ||||||
| Kendra Wong - Officer | Tax withholding / forfeiture | Common Stock | 864 footnote F1 | $5.39 | $5K | |
| ||||||
| Thomas R. Staab II - Officer | Option exercise | Common Stock | 5,500 | $2.65 | $15K | |
| Thomas R. Staab II - Officer | Option exercise | Stock Option (Right to Buy) | 5,500 | $0.00 | - | |
| Alan B. Connaughton - Officer | Tax withholding / forfeiture | Common Stock | 2,392 footnote F1 | $11.32 | $27K | |
| ||||||
| Thomas R. Staab II - Officer | Tax withholding / forfeiture | Common Stock | 1,076 footnote F1 | $11.32 | $12K | |
| ||||||
| Nicholas T. Curtis - Officer | Other | Common Stock | 0 footnote F1 | $0.00 | - | |
| ||||||
| Nicholas T. Curtis - Officer | Other | Common Stock | 0 footnote F1 | $0.00 | - | |
| ||||||
| Thomas R. Staab II - Officer | Tax withholding / forfeiture | Common Stock | 1,826 footnote F1 | $11.57 | $21K | |
| ||||||
| Alan B. Connaughton - Officer | Tax withholding / forfeiture | Common Stock | 2,262 footnote F1 | $11.57 | $26K | |
| ||||||
| Todd B. Hammer | Grant or award | Common Stock | 7,374 | $0.00 | - | |
| Thomas B. Ellis | Grant or award | Common Stock | 7,374 | $0.00 | - | |
| Richard L. Md Lindstrom | Grant or award | Common Stock | 7,374 | $0.00 | - | |
| William J. Phd Link | Grant or award | Common Stock | 7,374 | $0.00 | - | |
| Aimee S. Weisner | Grant or award | Common Stock | 7,374 | $0.00 | - | |
Item 2.02, 9.01
Item 5.07
Item 5.02, 5.08, 8.01
Item 2.02, 9.01
Recent LNSR Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
LNSR insider trading FAQ
What is the latest insider trade for LNSR?
LENSAR, Inc. (LNSR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-06. The full record for LNSR runs to 26 Form 4 filings, the earliest from 2025-05-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LNSR stock?
No insider purchases of LNSR were filed in the last 90 days.
How many insiders are selling LNSR stock?
No insider sales of LNSR were filed in the last 90 days.
Where can I see LNSR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LNSR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Todd B. Hammer view on EDGAR
- - Thomas B. Ellis view on EDGAR
- - Kendra Wong view on EDGAR
- - Alan B. Connaughton view on EDGAR
- - Nicholas T. Curtis view on EDGAR
- - Aimee S. Weisner view on EDGAR
- - Elizabeth G. O'Farrell view on EDGAR
- - Gary M. Winer view on EDGAR
- - Richard L. Md Lindstrom view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where LNSR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LNSR with a 7-day demo
- LNSR on your watchlist
- Every LNSR Form 4 filing on record
- Up to 3 months of LNSR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
